Uncategorized

FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes

The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.

Related posts
Uncategorized

French A.I. Start-Up Mistral Raises $3.5 Billion as Part of Strategy Shift

Mistral is trying to keep pace with American and Chinese rivals while offering customers a European…
Read more
Uncategorized

Canada Imposes New Tariffs on U.S. Goods, as Trade War Intensifies

The duties are a retaliation against President Trump’s recent tariffs, raising concerns about…
Read more
Uncategorized

China’s Surging Exports Loom Over Trump’s Talks With Xi

China’s exports grew by a quarter in the month of August, weeks before its leader, Xi Jinping, is…
Read more
Newsletter
Become a Trendsetter
Sign up for Davenport’s Daily Digest and get the best of Davenport, tailored for you.

Leave a Reply

Your email address will not be published. Required fields are marked *